trending Market Intelligence /marketintelligence/en/news-insights/trending/I3N-ubwrSR7MnCTLjIx-RA2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Healthpeak Properties lands new tenant for San Francisco campus development

Gauging Supply Chain Risk In Volatile Times

The Commercial Real Estate CRE Sector Feels the Impact of the Coronavirus

Credit Analytics Case Study Poundworld Retail Ltd

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Healthpeak Properties lands new tenant for San Francisco campus development

Healthpeak Properties Inc. signed a long-term lease with Janssen BioPharma Inc.

The company, which is part of the Johnson & Johnson Family of Cos., will occupy roughly 60% of phase II at The Shore at Sierra Point campus in South San Francisco on completion of its construction, expected in January 2022.

Under the terms of the lease, Janssen has expansion rights that can be exercised over the course of 2020.

Phase II of the five-building campus, which totals 620,000 square feet on a 23-acre site, includes an addition that will link the two class A life sciences buildings across three of the four floors. It spans 298,000 square feet, up from its initial planned space of 266,000 square feet.

Phase I, which covers 222,000 square feet, is nearing completion and is already 100% pre-leased to two tenants.